文献速递妇产影像泌尿生殖MR

宫颈癌患者程序性细胞死亡配体-1表达与表观扩散系数值的关联:一种有前景的患者免疫治疗选择工具

Association between programmed cell death ligand-1 expression in patients with cervical cancer and apparent diffusion coefficient values: a promising tool for patient´s immunotherapy selection.
PubMed 文献 · Eur Radiol · 2024-04-18

回顾性招募683例宫颈癌患者建立训练队列,前瞻性招募332例建立验证队列,用三种ROI勾画方法测量ADCmean、ADCss和ADCmin,发现ADCmin与PD-L1表达独立相关,基于ADCmin联合FIGO分期、病理分级、宫旁浸润和淋巴结状态的列线图在训练和验证队列中预测PD-L1表达的AUC分别为0.912和0.903,校准良好且净获益优于临床病理模型。

要点

  • ADCmin与宫颈癌PD-L1表达独立相关,可作为与PD-L1表达相关的影像生物标志物。
  • 基于ADCmin联合FIGO分期、病理分级、宫旁浸润和淋巴结状态的列线图预测PD-L1表达AUC训练队列0.912、验证队列0.903。
  • 该列线图校准良好且净获益优于临床病理模型,可能有助于临床免疫治疗决策。

核心结论

  • ADCmin与宫颈癌PD-L1表达独立相关,基于ADCmin和临床病理独立预后因素建立的列线图对PD-L1表达有较强预测性能,可能成为筛选适合免疫治疗病例的工具。

研究设计与样本

  • 回顾性招募683例宫颈癌患者建立训练队列,前瞻性招募332例宫颈癌患者建立验证队列。
  • 采用三种不同ROI勾画方法测量肿瘤的平均ADC(ADCmean)、单层ADC(ADCss)和最小ADC(ADCmin)。
  • 采用逻辑回归筛选与PD-L1表达相关的独立因素,基于ADC值联合临床病理特征绘制列线图,并以ROC曲线下面积和校准曲线评估区分度与校准度,以决策曲线分析评估临床获益。

诊断标准与关键数值

  • ADCmin与PD-L1表达独立相关。
  • 基于ADCmin联合FIGO分期、病理分级、宫旁浸润和淋巴结状态的列线图预测PD-L1表达的AUC在训练队列为0.912、在验证队列为0.903。

临床应用与阅片要点

  • 最小ADC可作为与PD-L1表达相关的可靠影像生物标志物。
  • 所建立的列线图联合最小ADC和临床病理因素,可辅助临床免疫治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the associations between apparent diffusion coefficient (ADC) values extracted from three different region of interest (ROI) position approaches and programmed cell death ligand-1 (PD-L1) expression, and evaluate the performance of the nomogram established based on ADC values and clinicopathological parameters in predicting PD-L1 expression in cervical cancer (CC) patients.

METHODS: Through retrospective recruitment, a training cohort of 683 CC patients was created, and a validation cohort of 332 CC patients was prospectively recruited. ROIs were delineated using three different methods to measure the mean ADC (ADCmean), single-section ADC (ADCss), and the minimum ADC of tumors (ADCmin). Logistic regression was employed to identify independent factors related to PD-L1 expression. A nomogram was drawn based on ADC values combined with clinicopathological features, its discrimination and calibration performances were estimated using the area under the curve (AUC) of receiver operating characteristic and calibration curve. The clinical benefits were evaluated by decision curve analysis.

RESULTS: The ADCmin independently correlated with PD-L1 expression. The nomogram constructed with ADCmin and other independent clinicopathological-related factors: FIGO staging, pathological grade, parametrial invasion, and lymph node status demonstrated excellent diagnostic performance (AUC = 0.912 and 0.903, respectively), good calibration capacities, and greater net benefits compared to the clinicopathological model in both the training and validation cohorts.

CONCLUSION: ADCmin independently correlated PD-L1 expression, and the nomogram established with ADCmin and clinicopathological independent prognostic factors had a strong predictive performance for PD-L1 expression, thereby serving as a promising tool for selecting cases eligible for immunotherapy.

CLINICAL RELEVANCE STATEMENT: The minimum ADC can serve as a reliable imaging biomarker related to PD-L1 expression; the established nomogram combines the minimum ADC and clinicopathological factors that can assist clinical immunotherapy decisions.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Liu K, Yang W, Tian H, et al. Association between programmed cell death ligand-1 expression in patients with cervical cancer and apparent diffusion coefficient values: a promising tool for patient´s immunotherapy selection. Eur Radiol. 2024. PMID: 38637428. doi:10.1007/s00330-024-10759-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。